Cargando…
Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model
Neuropsychological factors have been shown to influence tumor progression and therapeutic response. The present study investigated the effect of the dopamine receptor antagonist thioridazine on murine breast cancer. The anti-tumor efficacy of thioridazine was assessed using a murine breast cancer mo...
Autores principales: | YIN, TAO, HE, SISI, SHEN, GUOBO, YE, TINGHONG, GUO, FUCHUN, WANG, YONGSHENG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526087/ https://www.ncbi.nlm.nih.gov/pubmed/26095429 http://dx.doi.org/10.3892/mmr.2015.3967 |
Ejemplares similares
-
Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis
por: Lu, Meiling, et al.
Publicado: (2015) -
Antiangiogenic Therapy Using Sunitinib Combined with Rapamycin Retards Tumor Growth But Promotes Metastasis()
por: Yin, Tao, et al.
Publicado: (2014) -
HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer Model
por: Yin, Tao, et al.
Publicado: (2015) -
Effect of Thioridazine on Erythrocytes
por: Lang, Elisabeth, et al.
Publicado: (2013) -
Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator
por: Yin, Tao, et al.
Publicado: (2016)